February 2019, Volume 2, Issue 1

• Research ArticleP:7-10

  Liver enzyme activities in HIV seropositive pregnant women on Highly Active Antiretroviral Therapy (HAART)

  Ikekpeazu Joy E, Ibegbu Madu D, Onyekwelu Kenechukwu C, Uche Ozichukwuamaka S

  • Abstract

• Research ArticleP:11-17

  Initiation appropriateness, adverse drug reaction and adherence of isoniazid prophylaxis therapy among people living with human immune virus in Eastern Ethiopia: A cross-sectional study

  Ammas SM, Hunduma AB

  • Abstract

• Research ArticleP:18-24

  HIV outcomes for foreign-born patients receiving care at a safety net county health system in the southern US

  Christine Pack, Joan Reisch, Henry Pacheco, Arti Barnes

  • Abstract

December 2017, Volume 1, Issue 1

• Research ArticleP:12-16

  Gender and racial differences in enrollment and follow-up in a smoking clinical trial targeting people living with HIV: Implementation and preliminary outcomes

  Maria Jose M, Clery Q, Calonie G, Diego B, Castro G, Caroline P, Luis E

  • Abstract
  • PDF

• Research ArticleP:6-11

  Molecular epidemiology of human immunodeficiency virus type 1 and therapeutic monitoring of patients treated in Kinshasa/Democratic Republic of the Congo

  Erick Ntambwe Kamangu, Roger Di-Mosi Wumba, Hippolyte Nani-Tuma Situakibanza, Prosper tshiloba Lukusa, Liévin kalala Kapend, Georges lelo Mvumbi, Marie-pierre Hayette, Richard lunganza Kalala

  • Abstract
  • PDF

• EditorialP:1

  HIV resistance to anti-retroviral therapy in sub-Saharan Africa: Is it time for individualized treatment to succeed test and treat strategy?

  Jan René Nkeck*

  • Abstract
  • PDF